Who Paid My Doc
Maria Santos
Physical Medicine & Rehabilitation The Villages, FL Medical Doctor
NPI 1497758221 CMS profile 22093
1503 Buenos Aires Blvd Ste 180, The Villages, FL 32159
General payments
$1,163
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Maria Santos of The Villages, FL is reported in the CMS Open Payments database as having received $1,163 across 53 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 74th percentile of Physical Medicine & Rehabilitation profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $51 | 2 | |
| 2024 | General | $66 | 2 | |
| 2023 | General | $450 | 12 | |
| 2022 | General | $98 | 6 | |
| 2021 | General | $256 | 14 | |
| 2020 | General | $134 | 10 | |
| 2019 | General | $106 | 7 |
Beside peers
- Maria Santos
- Physical Medicine & Rehabilitation median
- Middle half of Physical Medicine & Rehabilitation
- National median
In program year 2025, general payments to Maria Santos were reported at $51. Among 4,146 Physical Medicine & Rehabilitation profiles paid that year, the median was $139 and the middle half received between $48 and $410.
Show as a table
| Year | Maria Santos | Physical Medicine & Rehabilitation median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $106 | $133 | $45–$390 | $163 |
| 2020 | $134 | $88 | $29–$272 | $114 |
| 2021 | $256 | $116 | $33–$360 | $132 |
| 2022 | $98 | $123 | $40–$378 | $149 |
| 2023 | $450 | $131 | $43–$396 | $160 |
| 2024 | $66 | $141 | $45–$409 | $164 |
| 2025 | $51 | $139 | $48–$410 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 27 drugsPart D claims
975
Drug cost
$55,967
Branded share of claims
16%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Santyl Collagenase Clostridium Hist. | Brand | 42 | $37,283 | |
| Gabapentin | Generic | 226 | $3,715 | |
| Pregabalin | Generic | 68 | $3,190 | |
| Duloxetine Hcl | Generic | 55 | $1,926 | |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | Brand | 45 | $1,380 | |
| Gentamicin Sulfate | Generic | 36 | $1,060 | |
| Baclofen | Generic | 30 | $1,005 | |
| Celecoxib | Generic | 28 | $870 | |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | Brand | 19 | $558 | |
| Alendronate Sodium | Generic | 15 | $527 |
The 10 drugs with the highest cost, of 27 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 7,591 Part D prescribers listed as Physical Medicine and Rehabilitation; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 54 billing codesPaid by Medicare
$765,823
Medicare patients
1,107
Services billed
25,175
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 75% | |
| Ischemic heart disease | 61% | |
| Chronic kidney disease | 56% | |
| Diabetes | 44% | |
| Atrial fibrillation | 42% | |
| Heart failure | 41% | |
| Depression | 39% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Injection, onabotulinumtoxina, 1 unit J0585 | Office | 23 | 17,300 | $86,095 |
| Injection, methylprednisolone acetate, 1 mg J1010 | Office | 36 | 1,280 | $129 |
| Injection, methylprednisolone acetate, 40 mg J1030 | Office | 12 | 13 | $60 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
53 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Physical Medicine & Rehabilitation in Florida
Anthony Giuffrida
Physical Medicine & Rehabilitation · Fort Lauderdale, FL
Ryan Hafner
Physical Medicine & Rehabilitation · Sarasota, FL
Cassandra List
Physical Medicine & Rehabilitation · Jacksonville, FL
Marissa McCarthy
Physical Medicine & Rehabilitation · Tampa, FL
Jose Medina Sanchez
Physical Medicine & Rehabilitation · Tampa, FL
Alan Miller
Physical Medicine & Rehabilitation · Fernandina Beach, FL
Related records
Physical Medicine & Rehabilitation in Florida
Practitioners in the same specialty and state, ranked by reported value.
All Physical Medicine & Rehabilitation
Everyone recorded under this specialty, nationwide.
Doctors in Florida
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.